Dartmouth researchers were awarded $5.5 million during December, including $1.1 million in new and competing awards. Among the recipients of recent new and competing grants, as reported by the Office of Sponsored Projects:
Ohio State University
"NitFhit: Structural and Molecular Pharmacology"
17-Month Award
Pfizer Inc.
"Effects of Cholesterol Metabolism on Ab Production"
Elsa Pardee Foundation
"Identification, Expression Profiling and Pilot Study to Assess the Diagnostic Value of microRNAs in Breast Cancer"
Olmsted Medical Center
"TRIP for Postpartum Depression (TRIPPD)"
5-Year Award
Virginia Commonwealth University
"Phase I Trial of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma"
Veteran's Administration
"VA Outcomes Group"
3-Year Award
Veteran's Administration
"VA/Surgical Volume"
3-Month Award
Thomas Jefferson University
"Improving Function in AMD Trial (IF-AMD)"
10-Month Award
State of Vermont
"VT Mental Health Employment Programs for Youth and Adults"
University of New Hampshire
"A University Affiliated Program in New Hampshire"
Amgen, Inc.
"A Randomized Open label Controlled Clinical Trial of Chemotherapy and Bevacizumab: The First Line Treatment of Subjects with Metastatic Colorectal Cancer"
University of Maryland
"Gyrokinetic Simulations of Turbulence and Magnetic Reconnection"
14-Month Award
Campus Compact
"Tucker-Faculty Collaboration: Prison Project, TELLING OUR STORIES"
9-Month Award
University of North Carolina
"Design of Diffractive Optics for Interference Lithography of Photonic Crystals"
6-Month Award
National Institutes of Health
"Ethanol Consumption and Muscarinic Tone in Medial Septum"
4-Year Award
Award commitment from the sponsoring agency is for a single year unless otherwise indicated.
